PISCATAWAY, N.J. — Camber Pharmaceuticals has expanded its cardiovascular portfolio by launching Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets, a generic version of Tribenzor indicated for the treatment of hypertension.
According to the Centers for Disease Control and Prevention, about 40% to 45% of U.S. adults have hypertension, underscoring the ongoing demand for accessible treatment options.
Camber’s new product is available in 30-count and 90-count bottles in the following strengths:
- 20 mg/5 mg/12.5 mg
- 40 mg/5 mg/12.5 mg
- 40 mg/5 mg/25 mg
- 40 mg/10 mg/12.5 mg
- 40 mg/10 mg/25 mg
The launch adds to Camber’s growing portfolio of generic medications, providing health care providers and pharmacies with additional treatment options across a range of therapeutic categories.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
